메뉴 건너뛰기




Volumn 8, Issue 4, 2003, Pages 315-320

B-type natriuretic peptide: Physiologic role and assay characteristics

Author keywords

B type natriuretic peptide; Immunoassay; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

EID: 0348155728     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026182912461     Document Type: Review
Times cited : (28)

References (40)
  • 1
    • 0034990519 scopus 로고    scopus 로고
    • B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure
    • Maisel A. B-type natriuretic peptide levels: A potential novel "white count" for congestive heart failure. J Cardiac Failure 2001;7:183-193.
    • (2001) J Cardiac Failure , vol.7 , pp. 183-193
    • Maisel, A.1
  • 2
    • 0032748389 scopus 로고    scopus 로고
    • Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans
    • Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Horm Metab Res 1999;31:487-498.
    • (1999) Horm Metab Res , vol.31 , pp. 487-498
    • Clerico, A.1    Iervasi, G.2    Mariani, G.3
  • 3
    • 0035882209 scopus 로고    scopus 로고
    • Plasma A- and B-type natriuretic peptides: Physiology, methodology and clinical use
    • Boomama F, Van Der Meiracker AH. Plasma A- and B-type natriuretic peptides: Physiology, methodology and clinical use. Cardiovasc Res 2001;51:442-449.
    • (2001) Cardiovasc Res , vol.51 , pp. 442-449
    • Boomama, F.1    Van Der Meiracker, A.H.2
  • 4
    • 0028070631 scopus 로고
    • Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans
    • Vesely DL, Douglass MA, Dietz JR, Gower WR Jr., McCormick MT, Rodriguez-Paz G, Schocken DD. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994;90:1129-1140.
    • (1994) Circulation , vol.90 , pp. 1129-1140
    • Vesely, D.L.1    Douglass, M.A.2    Dietz, J.R.3    Gower Jr., W.R.4    McCormick, M.T.5    Rodriguez-Paz, G.6    Schocken, D.D.7
  • 5
    • 0023730740 scopus 로고
    • Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine
    • Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 1988;66:752-759.
    • (1988) Klin Wochenschr , vol.66 , pp. 752-759
    • Schulz-Knappe, P.1    Forssmann, K.2    Herbst, F.3    Hock, D.4    Pipkorn, R.5    Forssmann, W.G.6
  • 6
    • 0037633093 scopus 로고    scopus 로고
    • Review of the clinical utility of NT-proBNP in the diagnosis, prognosis, and therapy monitoring of patients with congestive heart failure
    • Ambrose TM. Review of the clinical utility of NT-proBNP in the diagnosis, prognosis, and therapy monitoring of patients with congestive heart failure. J Clin Ligand Assay 2002;25:160-166.
    • (2002) J Clin Ligand Assay , vol.25 , pp. 160-166
    • Ambrose, T.M.1
  • 8
    • 0034911020 scopus 로고    scopus 로고
    • The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure
    • Mair J, Hammerer-Lercher A, Puchendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-588.
    • (2001) Clin Chem Lab Med , vol.39 , pp. 571-588
    • Mair, J.1    Hammerer-Lercher, A.2    Puchendorf, B.3
  • 9
    • 0028359997 scopus 로고
    • Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
    • Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
    • (1994) Circulation , vol.90 , pp. 195-203
    • Yasue, H.1    Yoshimura, M.2    Sumida, H.3    Kikuta, K.4    Kugiyama, K.5    Jougasaki, M.6    Ogawa, H.7    Okumura, K.8    Mukoyama, M.9    Nakao, K.10
  • 11
    • 0031822774 scopus 로고    scopus 로고
    • Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation
    • Selvais P, Donckier J, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest 1998;28:636-642.
    • (1998) Eur J Clin Invest , vol.28 , pp. 636-642
    • Selvais, P.1    Donckier, J.2    Robert, A.3
  • 12
    • 0029834931 scopus 로고    scopus 로고
    • Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
    • Yamamota K, Burnett J, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-994.
    • (1996) Hypertension , vol.28 , pp. 988-994
    • Yamamota, K.1    Burnett, J.2    Jougasaki, M.3
  • 13
    • 15444361735 scopus 로고    scopus 로고
    • Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
    • Clerico A, Iervasi G, Del Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-179.
    • (1998) J Endocrinol Invest , vol.21 , pp. 170-179
    • Clerico, A.1    Iervasi, G.2    Del Chicca, M.3
  • 14
    • 0024364093 scopus 로고
    • Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans
    • Janssen WM, De Zeeuw D, Van Der Hem GK, De Jong PE. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 1989;13:640-646.
    • (1989) Hypertension , vol.13 , pp. 640-646
    • Janssen, W.M.1    De Zeeuw, D.2    Van Der Hem, G.K.3    De Jong, P.E.4
  • 15
    • 0025729993 scopus 로고
    • Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
    • Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-1412.
    • (1991) J Clin Invest , vol.87 , pp. 1402-1412
    • Mukoyama, M.1    Nakao, K.2    Hosoda, K.3
  • 16
    • 0031862908 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
    • Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.
    • (1998) Am Heart J , vol.135 , pp. 825-832
    • Maeda, K.1    Tsutamoto, T.2    Wada, A.3    Hisanaga, T.4    Kinoshita, M.5
  • 18
    • 0031772642 scopus 로고    scopus 로고
    • Measurement and significance of circulating natriuretic peptides in cardiovascular disease
    • Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519-529.
    • (1998) Clin Sci , vol.95 , pp. 519-529
    • Sagnella, G.A.1
  • 19
    • 0031834174 scopus 로고    scopus 로고
    • Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
    • Stein B, Levin R. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. American Heart Journal 1998;135:914-923.
    • (1998) American Heart Journal , vol.135 , pp. 914-923
    • Stein, B.1    Levin, R.2
  • 21
    • 0027529321 scopus 로고
    • Cardiovascular actions of ANF: Contributions of renal, neurohumoral and hemodynamic factors in sheep
    • Charles CJ, Espiner EA, Richards AM. Cardiovascular actions of ANF: Contributions of renal, neurohumoral and hemodynamic factors in sheep. Am J Physiol 1993;264:R533-R538.
    • (1993) Am J Physiol , vol.264
    • Charles, C.J.1    Espiner, E.A.2    Richards, A.M.3
  • 24
    • 0032748389 scopus 로고    scopus 로고
    • Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans
    • Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Horm Metab Res 1999;31:487-498.
    • (1999) Horm Metab Res , vol.31 , pp. 487-498
    • Clerico, A.1    Iervasi, G.2    Mariani, G.3
  • 27
    • 0032998458 scopus 로고    scopus 로고
    • Promises and perils of managed care for older patients with cardiac disease
    • Friesinger GC, Francis J. Promises and perils of managed care for older patients with cardiac disease. Cardiol Clin 1999;17:67-77.
    • (1999) Cardiol Clin , vol.17 , pp. 67-77
    • Friesinger, G.C.1    Francis, J.2
  • 28
    • 0031451960 scopus 로고    scopus 로고
    • Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice
    • Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, Ford I, McMurray JJ, Dargie HJ. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice. Heart 1997;78:594-597.
    • (1997) Heart , vol.78 , pp. 594-597
    • Murdoch, D.R.1    Byrne, J.2    Morton, J.J.3    McDonagh, T.A.4    Robb, S.D.5    Clements, S.6    Ford, I.7    McMurray, J.J.8    Dargie, H.J.9
  • 29
    • 0031694450 scopus 로고    scopus 로고
    • Prolonged stability of brain natriuretic peptide: Importance for non-invasive assessment of cardiac function in clinical practice
    • Buckley MG, Marcus NJ, Yacoub MH, et al. Prolonged stability of brain natriuretic peptide: Importance for non-invasive assessment of cardiac function in clinical practice. Clin Sci 1998;95:235-239.
    • (1998) Clin Sci , vol.95 , pp. 235-239
    • Buckley, M.G.1    Marcus, N.J.2    Yacoub, M.H.3
  • 31
    • 0035104757 scopus 로고    scopus 로고
    • Measurement and importance of plasma brain natriuretic peptide and related peptides
    • Sagnella GA. Measurement and importance of plasma brain natriuretic peptide and related peptides. Ann Clin Biochem 2001;38:83-93.
    • (2001) Ann Clin Biochem , vol.38 , pp. 83-93
    • Sagnella, G.A.1
  • 32
    • 0001959587 scopus 로고
    • Immunoradiometric assay for brain natriuretic peptide in human plasma
    • Kono M, Yamauchi A, Tsuji T, et al. Immunoradiometric assay for brain natriuretic peptide in human plasma. Jpn Soc Nucl Med Technol 1993;13:2-7.
    • (1993) Jpn Soc Nucl Med Technol , vol.13 , pp. 2-7
    • Kono, M.1    Yamauchi, A.2    Tsuji, T.3
  • 34
    • 0035068002 scopus 로고    scopus 로고
    • A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
    • Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Fail 2001;7:21-29.
    • (2001) J Card Fail , vol.7 , pp. 21-29
    • Kazanegra, R.1    Cheng, V.2    Garcia, A.3    Krishnaswamy, P.4    Gardetto, N.5    Clopton, P.6    Maisel, A.7
  • 35
    • 0034982467 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared
    • Del Ry S, Giannessi D, Clerico A. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared. Clin Chem Lab Med 2001;39:446-450.
    • (2001) Clin Chem Lab Med , vol.39 , pp. 446-450
    • Del Ry, S.1    Giannessi, D.2    Clerico, A.3
  • 36
    • 0035147273 scopus 로고    scopus 로고
    • B-type natriuretic peptide (BNP) - Validation of an immediate response assay
    • Vogeser M, Jacob K. B-type natriuretic peptide (BNP) - Validation of an immediate response assay. Clin Lab 2001;47:29-33.
    • (2001) Clin Lab , vol.47 , pp. 29-33
    • Vogeser, M.1    Jacob, K.2
  • 37
    • 0037130176 scopus 로고    scopus 로고
    • B-type natriuretic peptide - A window to the heart
    • Baughman KL. B-type natriuretic peptide - A window to the heart. N Engl J Med 2002;347:158-159.
    • (2002) N Engl J Med , vol.347 , pp. 158-159
    • Baughman, K.L.1
  • 38
    • 0043279510 scopus 로고    scopus 로고
    • A novel assay for the measurement of plasma B-type Natriuretic Peptide by an AxSYM® microparticle based immunoassay with use of stable liquid calibrators
    • Abst # C-67.
    • Kelly PM, Gaston S, Mackay R, Arthur K, Taylor V, Shih J, Matias M, Friese J, Weigand R. A novel assay for the measurement of plasma B-type Natriuretic Peptide by an AxSYM® microparticle based immunoassay with use of stable liquid calibrators. Clin Chem 2002;48(suppl):A94, Abst # C-67.
    • (2002) Clin Chem , vol.48 , Issue.SUPPL.
    • Kelly, P.M.1    Gaston, S.2    Mackay, R.3    Arthur, K.4    Taylor, V.5    Shih, J.6    Matias, M.7    Friese, J.8    Weigand, R.9
  • 39
    • 0042277107 scopus 로고    scopus 로고
    • Development of an automated test for B-type natriuretic peptide (BNP) as an aid in the diagnosis and evaluation of congestive heart failure on the Bayer ADVIA Centaur chemiluminescent system
    • Abst # C-37.
    • Bluestein BI, Belenky A, Lin S, Despres N, Vajdi M, Armstrong G. Development of an automated test for B-type natriuretic peptide (BNP) as an aid in the diagnosis and evaluation of congestive heart failure on the Bayer ADVIA Centaur chemiluminescent system. Clin Chem 2002;48(suppl):A85, Abst # C-37.
    • (2002) Clin Chem , vol.48 , Issue.SUPPL.
    • Bluestein, B.I.1    Belenky, A.2    Lin, S.3    Despres, N.4    Vajdi, M.5    Armstrong, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.